(Q39970885)

16 September 2017

Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas (English)

1 reference

16 September 2017

Christine Decaestecker

6

object named as

Christine Decaestecker

0 references

author name string

Sandrine Rorive

1

1 reference

16 September 2017

Alix Berton

2

1 reference

16 September 2017

Nicky D'haene

3

1 reference

16 September 2017

Constantin Nicolae Takacs

4

1 reference

16 September 2017

Olivier Debeir

5

1 reference

16 September 2017

Christine Decaestecker

6

1 reference

16 September 2017

Isabelle Salmon

7

1 reference

16 September 2017

language of work or name

1 reference

1 November 2008

1 reference

16 September 2017

1 reference

16 September 2017

56

1 reference

16 September 2017

15

1 reference

16 September 2017

1679-1690

1 reference

Proteases, extracellular matrix, and cancer: a workshop of the path B study section

16 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Insulin-like growth factor binding protein proteolysis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Enhanced production and proteolytic degradation of insulin-like growth factor binding protein-2 in proliferating rat astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Proteolysis of Insulin-Like Growth Factors (IGF) and IGF Binding Proteins by Cathepsin D1

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Matrix metalloprotease-3 and -9 proteolyze insulin-like growth factor-binding protein-1.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

The TIMPs tango with MMPs and more in the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Tracking of migrating cells under phase-contrast video microscopy with combined mean-shift processes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Cellular actions of the insulin-like growth factor binding proteins

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Collective cell migration in morphogenesis and cancer

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Insulin-like growth factors control cell migration in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Matrix metalloproteinases: they're not just for matrix anymore!

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: modulation by transforming growth factor-beta and retinoic acid

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Insulin-like growth factors (IGF) enhance three-dimensional (3D) growth of human glioblastomas.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Molecular mechanisms of glioma invasiveness: the role of proteases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Involvement of IGF-II in human cancer.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Insulin-like growth factor type I biology and targeting in malignant gliomas

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20719

7 January 2021

Identifiers

DOI

10.1002/GLIA.20719

1 reference

16 September 2017

1 reference